Ceranib-2-induced suicidal erythrocyte death

Cell Biochemistry and Function

Volumn 34, Issue 5, 2016, Pages 359-366

  Signoretto, Elena ^a,b   Zierle, Jens ^a   Bhuyan, Abdulla Al Mamun ^a   Castagna, Michela ^b   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

calcium; cell volume; eryptosis; oxidative stress; phosphatidylserine

Indexed keywords

ACID CERAMIDASE; CALCIUM ION; CERAMIDE; CERANIB 2; HYDROLASE INHIBITOR; LIPOCORTIN 5; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; CALCIUM CELL LEVEL; CELL DEATH; CELL SURFACE; CELL VOLUME; CONTROLLED STUDY; ERYPTOSIS; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; FLUORESCENCE; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; SUPERNATANT;

EID: 84976592391     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3196     Document Type: Article

References (124)

1. Abou-Ghali M, Stiban J. Regulation of ceramide channel formation and disassembly: insights on the initiation of apoptosis. Saudi J Biol Sci 2015; 22: 760–772. doi:10.1016/j.sjbs.2015.03.005.
2. Arana L, Gangoiti P, Ouro A, Trueba M, Gomez-Munoz A. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis 2010; 9: 15. doi:10.1186/1476-511X-9–15.
3. Arboleda G, Morales LC, Benitez B, Arboleda H. Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration. Brain Res Rev 2009; 59: 333–346. doi:10.1016/j.brainresrev.2008.10.001.
4. Aureli M, Murdica V, Loberto N, et al. Exploring the link between ceramide and ionizing radiation. Glycoconj J 2014; 31: 449–459. doi:10.1007/s10719-014-9541-y.
5. Ballereau S, Levade T, Genisson Y, Andrieu-Abadie N. Alteration of ceramide 1-O-functionalization as a promising approach for cancer therapy. Anticancer Agents Med Chem 2012; 12: 316–328.
6. Boslem E, Meikle PJ, Biden TJ. Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction. Islets 2012; 4: 177–187. doi:10.4161/isl.20102.
7. Chen H, Tran JT, Brush RS, et al. Ceramide signaling in retinal degeneration. Adv Exp Med Biol 2012; 723: 553–558. doi:10.1007/978-1-4614-0631-0_70.
8. Chen SD, Yin JH, Hwang CS, Tang CM, Yang DI. Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia. Free Radic Res 2012; 46: 940–950. doi:10.3109/10715762.2012.674640.
9. Claus RA, Dorer MJ, Bunck AC, Deigner HP. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate. Curr Med Chem 2009; 16: 1978–2000.
10. Colombini M. Ceramide channels and their role in mitochondria-mediated apoptosis. Biochim Biophys Acta 2010; 1797: 1239–1244. doi:10.1016/j.bbabio.2010.01.021.
11. Colombini M. Membrane channels formed by ceramide. Handb Exp Pharmacol 2013: 109–126. doi:10.1007/978-3-7091-1368-4_6.
12. Dimanche-Boitrel MT, Rebillard A, Gulbins E. Ceramide in chemotherapy of tumors. Recent Pat Anticancer Drug Discov 2011; 6: 284–293. doi:10.2174/157489211796957838.
13. Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Tumor suppressive functions of ceramide: evidence and mechanisms. Apoptosis 2015; 20: 689–711. doi:10.1007/s10495-015-1109-1.
14. Ganesan V, Colombini M. Regulation of ceramide channels by Bcl-2 family proteins. FEBS Lett 2010; 584: 2128–2134. doi:10.1016/j.febslet.2010.02.032.
15. Goldkorn T, Filosto S. Lung injury and cancer: mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol 2010; 43: 259–268. doi:10.1165/rcmb.2010-0220RT.
16. Goldkorn T, Filosto S, Chung S. Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor. Antioxid Redox Signal 2014; 21: 2149–2174. doi:10.1089/ars.2013.5469.
17. Gomez-Munoz A, Presa N, Gomez-Larrauri A, Rivera IG, Trueba M, Ordonez M. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res 2016; 61: 51–62. doi:10.1016/j.plipres.2015.09.002.
18. Grassme H, Becker KA. Bacterial infections and ceramide. Handb Exp Pharmacol 2013: 305–320. doi:10.1007/978-3-7091-1511-4_15.
19. Hage-Sleiman R, Esmerian MO, Kobeissy H, Dbaibo G. p53 and Ceramide as Collaborators in the Stress Response. Int J Mol Sci 2013; 14: 4982–5012. doi:10.3390/ijms14034982.
20. Henry B, Moller C, Dimanche-Boitrel MT, Gulbins E, Becker KA. Targeting the ceramide system in cancer. Cancer Lett 2013; 332: 286–294. doi:10.1016/j.canlet.2011.07.010.
21. Hinkovska-Galcheva V, Shayman JA. Ceramide-1-phosphate in phagocytosis and calcium homeostasis. Adv Exp Med Biol 2010; 688: 131–140.
22. Jana A, Hogan EL, Pahan K. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci 2009; 278: 5–15. doi:10.1016/j.jns.2008.12.010.
23. Kartal Yandim M, Apohan E, Baran Y. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer. Cancer Chemother Pharmacol 2013; 71: 13–20. doi:10.1007/s00280-012-1984-x.
24. Kawamori T. Animal models for studying the pathophysiology of ceramide. Adv Exp Med Biol 2010; 688: 109–117.
25. Kogot-Levin A, Saada A. Ceramide and the mitochondrial respiratory chain. Biochimie 2014; 100: 88–94. doi:10.1016/j.biochi.2013.07.027.
26. Lang F, Ullrich S, Gulbins E. Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets 2011; 15: 1061–1071. doi:10.1517/14728222.2011.588209.
27. Levi M, Meijler MM, Gomez-Munoz A, Zor T. Distinct receptor-mediated activities in macrophages for natural ceramide-1-phosphate (C1P) and for phospho-ceramide analogue-1 (PCERA-1). Mol Cell Endocrinol 2010; 314: 248–255. doi:10.1016/j.mce.2009.05.007.
28. Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life 2010; 62: 347–356. doi:10.1002/iub.319.
29. Li F, Zhang N. Ceramide: therapeutic potential in combination therapy for cancer treatment. Curr Drug Metab 2015; 17: 37–51.
30. Liu J, Beckman BS, Foroozesh M. A review of ceramide analogs as potential anticancer agents. Future Med Chem 2013; 5: 1405–1421. doi:10.4155/fmc.13.107.
31. Morad SA, Cabot MC. Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 2013; 13: 51–65. doi:10.1038/nrc3398.
32. Mullen TD, Obeid LM. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem 2012; 12: 340–363.
33. Novgorodov SA, Gudz TI. Ceramide and mitochondria in ischemic brain injury. Int J Biochem Mol Biol 2011; 2: 347–361.
34. Petrache I, Petrusca DN, Bowler RP, Kamocki K. Involvement of ceramide in cell death responses in the pulmonary circulation. Proc Am Thorac Soc 2011; 8: 492–496. doi:10.1513/pats.201104-034MW.
35. Ponnusamy S, Meyers-Needham M, Senkal CE, et al. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 2010; 6: 1603–1624. doi:10.2217/fon.10.116.
36. Rivera IG, Ordonez M, Presa N, et al. Sphingomyelinase D/ceramide 1-phosphate in cell survival and inflammation. Toxins (Basel) 2015; 7: 1457–1466. doi:10.3390/toxins7051457.
37. Saddoughi SA, Ogretmen B. Diverse functions of ceramide in cancer cell death and proliferation. Adv Cancer Res 2013; 117: 37–58. doi:10.1016/B978-0-12-394274-6.00002-9.
38. Uchida Y. Ceramide signaling in mammalian epidermis. Biochim Biophys Acta 2014; 1841: 453–462. doi:10.1016/j.bbalip.2013.09.003.
39. Ueda N. Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate. Int J Mol Sci 2015; 16: 5076–5124. doi:10.3390/ijms16035076.
40. Van Brocklyn JR, Williams JB. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B Biochem Mol Biol 2012; 163: 26–36. doi:10.1016/j.cbpb.2012.05.006.
41. Voelzmann A, Bauer R. Ceramide synthases in mammalians, worms, and insects: emerging schemes. Biomol Concepts 2010; 1: 411–422. doi:10.1515/bmc.2010.028.
42. Liu X, Cheng JC, Turner LS, et al. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy. Expert Opin Ther Targets 2009; 13: 1449–1458. doi:10.1517/14728220903357512.
43. Liu X, Elojeimy S, Turner LS, et al. Acid ceramidase inhibition: a novel target for cancer therapy. Front Biosci 2008; 13: 2293–2298.
44. Park JH, Schuchman EH. Acid ceramidase and human disease. Biochim Biophys Acta 2006; 1758: 2133–2138. doi:10.1016/j.bbamem.2006.08.019.
45. Zeidan YH, Jenkins RW, Korman JB, et al. Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets 2008; 9: 653–661.
46. Draper JM, Xia Z, Smith RA, Zhuang Y, Wang W, Smith CD. Discovery and evaluation of inhibitors of human ceramidase. Mol Cancer Ther 2011; 10: 2052–2061. doi:10.1158/1535-7163.MCT-11-0365.
47. Kus G, Kabadere S, Uyar R, Kutlu HM. Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2. In Vitro Cell Dev Biol Anim 2015; 51: 1056–1063. doi:10.1007/s11626-015-9932-9.
48. Vethakanraj HS, Babu TA, Sudarsanan GB, Duraisamy PK, Ashok KS. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines. Biochem Biophys Res Commun 2015; 464: 833–839. doi:10.1016/j.bbrc.2015.07.047.
49. Tseng CH, Tzeng CC, Hsu CY, Cheng CM, Yang CN, Chen YL. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers. Eur J Med Chem 2015; 97: 306–319. doi:10.1016/j.ejmech.2015.04.054.
50. Lang E, Bissinger R, Gulbins E, Lang F. Ceramide in the regulation of eryptosis, the suicidal erythrocyte death. Apoptosis 2015; 20: 758–767. doi:10.1007/s10495-015-1094-4.
51. Qadri SM, Bauer J, Zelenak C, et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem 2011; 28: 339–346. doi:10.1159/000331750.
52. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2 + -activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003; 285: C1553–C1560.
53. Lang E, Lang F. Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death. Semin Cell Dev Biol 2015; 39: 35–42. doi:10.1016/j.semcdb.2015.01.009.
54. Lau IP, Chen H, Wang J, et al. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012; 6: 847–856. doi:10.3109/17435390.2011.625132.
55. Maellaro E, Leoncini S, Moretti D, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013; 50: 489–495. doi:10.1007/s00592-011-0274-0.
56. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 2012; 29: 171–180. doi:10.1159/000337598.
57. Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011; 27: 547–556. doi:10.1159/000329956.
58. Klarl BA, Lang PA, Kempe DS, et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006; 290: C244–253. doi:10.1152/ajpcell.00283.2005.
59. Gatidis S, Zelenak C, Fajol A, et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011; 28: 1279–1286. doi:10.1159/000335859.
60. Foller M, Sopjani M, Koka S, et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009; 23: 1072–1080. doi:10.1096/fj.08-121772.
61. Foller M, Feil S, Ghoreschi K, et al. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci U S A 2008; 105: 6771–6776. doi:10.1073/pnas.0708940105.
62. Lang E, Bissinger R, Fajol A, et al. Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2. Sci Rep 2015; 5: 17316. doi:10.1038/srep17316.
63. Zelenak C, Foller M, Velic A, et al. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011; 10: 1690–1697. doi:10.1021/pr101004j.
64. Lupescu A, Shaik N, Jilani K, et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 2012; 30: 876–888. doi:10.1159/000341465.
65. Shaik N, Lupescu A, Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 2012; 30: 512–522. doi:10.1159/000341434.
66. Alzoubi K, Calabròa S, Bissinger R, Abed M, Faggio C, Lang F. Stimulation of suicidal erythrocyte death by artesunate. Cell Physiol Biochem 2014; 34: 2232–2244.
67. Alzoubi K, Egler J, Abed M, Lang F. Enhanced eryptosis following auranofin exposure. Cell Physiol Biochem 2015; 37: 1018–1028. doi:10.1159/000430228.
68. Arnold M, Lang E, Modicano P, et al. Effect of nitazoxanide on erythrocytes. Basic Clin Pharmacol Toxicol 2014; 114: 421–426. doi:10.1111/bcpt.12171.
69. Bissinger R, Bouguerra G, Stockinger K, Abbes S, Lang F. Triggering of suicidal erythrocyte death by topotecan. Cell Physiol Biochem 2015; 37: 1607–1618. doi:10.1159/000438527.
70. Bissinger R, Lupescu A, Zelenak C, Jilani K, Lang F. Stimulation of eryptosis by cryptotanshinone. Cell Physiol Biochem 2014; 34: 432–442. doi:10.1159/000363012.
71. Bouguerra G, Bissinger R, Abbes S, Lang F. Stimulation of Eryptosis by Narasin. Cell Physiol Biochem 2015; 37: 1807–1816. doi:10.1159/000438543.
72. Bouguerra G, Bissinger R, Abbes S, Lang F. Zopolrestat induced suicidal death of human erythrocytes. Cell Physiol Biochem 2015; 37: 1537–1546. doi:10.1159/000438521.
73. Briglia M, Fazio A, Signoretto E, Faggio C, Lang F. Edelfosine induced suicidal death of human erythrocytes. Cell Physiol Biochem 2015; 37: 2221–2230. doi:10.1159/000438578.
74. Calabro S, Alzoubi K, Faggio C, Laufer S, Lang F. Triggering of suicidal erythrocyte death following boswellic acid exposure. Cell Physiol Biochem 2015; 37: 131–142. doi:10.1159/000430339.
75. Egler J, Lang F. Licochalcone A Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 2060–2070. doi:10.1159/000438565.
76. Fazio A, Briglia M, Faggio C, Alzoubi K, Lang F. Stimulation of suicidal erythrocyte death by garcinol. Cell Physiol Biochem 2015; 37: 805–815. doi:10.1159/000430397.
77. Jacobi J, Lang E, Bissinger R, et al. Stimulation of erythrocyte cell membrane scrambling by mitotane. Cell Physiol Biochem 2014; 33: 1516–1526. doi:10.1159/000358715.
78. Lang E, Zelenak C, Eberhard M, et al. Impact of Cyclin-Dependent Kinase CDK4 Inhibition on Eryptosis. Cell Physiol Biochem 2015; 37: 1178–1186. doi:10.1159/000430241.
79. Lupescu A, Bissinger R, Goebel T, et al. Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem 2015; 36: 773–783. doi:10.1159/000430137.
80. Lupescu A, Bissinger R, Warsi J, Jilani K, Lang F. Stimulation of erythrocyte cell membrane scrambling by gedunin. Cell Physiol Biochem 2014; 33: 1838–1848. doi:10.1159/000362962.
81. Malik A, Bissinger R, Calabro S, Faggio C, Jilani K, Lang F. Aristolochic acid induced suicidal erythrocyte death. Kidney Blood Press Res 2014; 39: 408–419. doi:10.1159/000368454.
82. Officioso A, Alzoubi K, Manna C, Lang F. Clofazimine Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 331–341. doi:10.1159/000430357.
83. Oswald G, Alzoubi K, Abed M, Lang F. Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin Pharmacol Toxicol 2014; 114: 311–317. doi:10.1111/bcpt.12165.
84. Peter T, Bissinger R, Enkel S, Alzoubi K, Oswald G, Lang F. Programmed erythrocyte death following in vitro Treosulfan treatment. Cell Physiol Biochem 2015; 35: 1372–1380. doi:10.1159/000373958.
85. Stockinger K, Bissinger R, Bouguerra G, Abbes S, Lang F. Enhanced eryptosis following exposure to carnosic acid. Cell Physiol Biochem 2015; 37: 1779–1791. doi:10.1159/000438541.
86. Tesoriere L, Attanzio A, Allegra M, Cilla A, Gentile C, Livrea MA. Oxysterol mixture in hypercholesterolemia-relevant proportion causes oxidative stress-dependent eryptosis. Cell Physiol Biochem 2014; 34: 1075–1089. doi:10.1159/000366322.
87. Waibel S, Bissinger R, Bouguerra G, Abbes S, Lang F. Saquinavir induced suicidal death of human erythrocytes. Cell Physiol Biochem 2015; 37: 1973–1982. doi:10.1159/000438558.
88. Zierle J, Bissinger R, Egler J, Lang F. Lapatinib Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 2275–2287. doi:10.1159/000438583.
89. Bissinger R, Bouguerra G, Al Mamun Bhuyan A, Waibel S, Abbes S, Lang F. Efavirenz induced suicidal death of human erythrocytes. Cell Physiol Biochem 2015; 37: 2496–2507. doi:10.1159/000438602.
90. Bissinger R, Waibel S, Bouguerra G, Al Mamun Bhuyan A, Abbes S, Lang F. Enhanced Eryptosis Following Exposure to Lopinavir. Cell Physiol Biochem 2015; 37: 2486–2495. doi:10.1159/000438601.
91. Briglia M, Calabro S, Signoretto E, et al. Fucoxanthin induced suicidal death of human erythrocytes. Cell Physiol Biochem 2015; 37: 2464–2475. doi:10.1159/000438599.
92. Briglia M, Fazio A, Faggio C, Lang F. Triggering of suicidal erythrocyte death by zosuquidar. Cell Physiol Biochem 2015; 37: 2355–2365. doi:10.1159/000438589.
93. Fazio A, Briglia M, Faggio C, Alzoubi K, Lang F. Oxaliplatin induced suicidal death of human erythrocytes. Cell Physiol Biochem 2015; 37: 2393–2404. doi:10.1159/000438592.
94. Macczak A, Cyrkler M, Bukowska B, Michalowicz J. Eryptosis-inducing activity of bisphenol a and its analogs in human red blood cells (in vitro study). J Hazard Mater 2016; 307: 328–335. doi:10.1016/j.jhazmat.2015.12.057.
95. Officioso A, Alzoubi K, Lang F, Manna C. Hydroxytyrosol inhibits phosphatidylserine exposure and suicidal death induced by mercury in human erythrocytes: Possible involvement of the glutathione pathway. Food Chem Toxicol 2016; 89: 47–53. doi:10.1016/j.fct.2016.01.003.
96. Officioso A, Manna C, Alzoubi K, Lang F. Bromfenvinphos induced suicidal death of human erythrocytes. Pestic Biochem Physiol 2016; 126: 58–63. doi:10.1016/j.pestbp.2015.07.007.
97. Qadri SM, Donkor DA, Bhakta V, et al. Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin. J Cell Mol Med 2016. doi:10.1111/jcmm.12778.
98. Zierle J, Bissinger R, Bouguerra G, Abbes S, Lang F. Triggering of suicidal erythrocyte death by regorafenib. Cell Physiol Biochem 2016; 38: 160–172. doi:10.1159/000438618.
99. Pagano M, Faggio C. The use of erythrocyte fragility to assess xenobiotic cytotoxicity. Cell Biochem Funct 2015; 33: 351–355. doi:10.1002/cbf.3135.
100. Faggio C, Alzoubi K, Calabro S, Lang F. Stimulation of suicidal erythrocyte death by PRIMA-1. Cell Physiol Biochem 2015; 35: 529–540. doi:10.1159/000369717.
101. Bissinger R, Barking S, Alzoubi K, Liu G, Liu G, Lang F. Stimulation of suicidal erythrocyte death by the antimalarial drug mefloquine. Cell Physiol Biochem 2015; 36: 1395–1405. doi:10.1159/000430305.
102. Bouguerra G, Aljanadi O, Bissinger R, Abbes S, Lang F. Embelin-induced phosphatidylserine translocation in the erythrocyte cell membrane. Cell Physiol Biochem 2015; 37: 1629–1640. doi:10.1159/000438529.
103. Ran Q, Xiang Y, Liu Y, et al. Eryptosis indices as a novel predictive parameter for biocompatibility of Fe3O4 magnetic nanoparticles on erythrocytes. Sci Rep 2015; 5: 16209. doi:10.1038/srep16209.
104. Abed M, Feger M, Alzoubi K, et al. Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 2013; 37: 567–578. doi:10.1159/000355737.
105. Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F. Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 2013; 38: 42–51. doi:10.1159/000355752.
106. Abed M, Artunc F, Alzoubi K, et al. Suicidal erythrocyte death in end-stage renal disease. J Mol Med 2014; 92: 871–879. doi:10.1007/s00109-014-1151-4.
107. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013; 37: 158–167. doi:10.1159/000350141.
108. Polak-Jonkisz D, Purzyc L. Ca(2+) influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 2012; 34: 209–210; author reply 210. doi:10.1159/000341627.
109. Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, et al. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem 2011; 357: 171–179. doi:10.1007/s11010-011-0887-1.
110. Lang PA, Beringer O, Nicolay JP, et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006; 84: 378–388. doi:10.1007/s00109-006-0058-0.
111. Nicolay JP, Schneider J, Niemoeller OM, et al. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006; 18: 223–232. doi:10.1159/000097669.
112. Lang E, Gatidis S, Freise NF, et al. Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 2015; 61: 275–284. doi:10.1002/hep.27338.
113. Kempe DS, Akel A, Lang PA, et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007; 85: 273–281. doi:10.1007/s00109-006-0123-8.
114. Lang PA, Schenck M, Nicolay JP, et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13: 164–170. doi:10.1038/nm1539.
115. Harrison HE, Bunting H, Ordway NK, Albrink WS. The pathogenesis of the renal injury produced in the Dog by hemoglobin or methemoglobin. J Exp Med 1947; 86: 339–356.
116. Abed M, Towhid ST, Mia S, et al. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012; 303: C991–999. doi:10.1152/ajpcell.00239.2012.
117. Borst O, Abed M, Alesutan I, et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012; 302: C644–C651.
118. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999; 6: 76–82.
119. Chung SM, Bae ON, Lim KM, et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007; 27: 414–421.
120. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62: 971–988.
121. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999; 107: 300–302.
122. Gallagher PG, Chang SH, Rettig MP, et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003; 101: 4625–4627.
123. Pandolfi A, Di Pietro N, Sirolli V, et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007; 213: 699–709.
124. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996; 88: 1873–1880.